• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

Skin disease price tag tops $37 billion annually

Article

National report — The first-ever study attempting to assess the total burden of skin disease indicates that the toll exacted from Americans has been underestimated.

Related Videos
Related Content
Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea

Review Finds Topical Erythromycin, Azithromycin, and Metronidazole Most Common Treatments for Pediatric Rosacea

Article
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis

Podcast
Camp Wonder: Supporting Children With Life-Threatening Skin Diseases

Camp Wonder: Supporting Children With Life-Threatening Skin Diseases

Article
The Cutaneous Connection

The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma

Podcast
Given Prevalence, Study Underscores Need for Education Surrounding Pediatric Dermatoses in Patients With Skin of Color

Given Prevalence, Study Underscores Need for Education Surrounding Pediatric Dermatoses in Patients With Skin of Color

Article
FDA Approves Roflumilast Cream 0.3% In Children 6 to 11 Years With PsO

FDA Approves Roflumilast Cream 0.3% In Children 6 to 11 Years With PsO

Article
© 2023 MJH Life Sciences

All rights reserved.